Addressing Bias in AI To Build Trust in Technology with Dr. Rashawn Ray, Vice President of AIR, Executive Director of AIR Equity Initiative

In this episode, I’m joined by Dr. Rashawn Ray, Vice President at the American Institutes for Research (AIR) and Executive Director of AIR Equity Initiative, Professor of Sociology at the University of Maryland and Senior Fellow at The Brookings Institution. Dr. Ray’s innovative work lies at the powerful intersection of policing, technology and social equity, where he explores how AI can be designed and implemented to enhance fairness, reduce inequality and ultimately be a force for positive change in both local communities and the broader world.

Key Takeaways:

(01:00) Regulating AI without stifling innovation is crucial.
(07:06) How virtual reality enhances police training by addressing implicit bias.

(12:22) The impact of diverse teams on equitable AI development.
(19:36) Overcoming challenges in implementing VR training in smaller law enforcement agencies.
(25:50) Tech companies collaborating on socially impactful AI projects is vital.
(31:55) Community involvement is critical in shaping AI and VR technologies.
(36:21) The role of DEI initiatives in improving AI’s fairness and effectiveness.
(42:09) The future of AI legislation and its potential to democratize technology.

Resources Mentioned:

AIR website

AIR Equity Initiative

Lab for Applied Social Science Research

Brookings Institution

Dr. Rashawn Ray - AIR 

Dr. Rashan Ray’s website
“Extracting Protest Events from Newspaper Articles with ChatGPT” (working paper)
“5 questions policymakers should ask about facial recognition, law enforcement and algorithmic bias”
“Examining equity in transportation safety enforcement”



Thanks for listening to the Regulating AI: Innovate Responsibly podcast. If you enjoyed this episode, please leave a 5-star review to help get the word out about the show. And be sure to subscribe so you never miss another insightful conversation.


#AIRegulation #AISafety #AIStandard

Previous
Previous

AI's Role in Accelerating Drug Development and Clinical Trials with Raphael Townshend, PhD, Founder and CEO of Atomic AI

Next
Next

Regulating AI Innovation for National Security and Healthcare with Mike Rounds, US Senator for South Dakota, Co-Chair of the Senate AI Caucus and Member of the Bipartisan Senate AI Working Group